BioMimetic Therapeutics (BMTI)
Cytori Therapeutics (CYTX)
RTI Biologics (RTIX)
Aastrom Biosciences (ASTM)
Mesoblast (MBLTY)
Neuralstem (CUR)
Osteotech (OSTE)
ThermoGenesis (KOOL)
RegeneRx Biopharma (RGN)
Advanced Cell Tecchology (ACTC)
Pluristem Therapeutics (PSTI)
Athersys (ATHX)
International Stem Cell Corp (ISCO)
Stem Cell Innovations (SCLL)
Bioheart (BHRT)
CellCyte Genetics Corp (CCYG)
Stem Cell Therapeutics (SCTPF)
Brainstorm Cell Therapeutics (BCLI)
Opexa Therapeutics (OPXA)
Stem Cell Authority (SCAL)
Neostem (NBS)
Stem Cell Therapy Internt'l (SCII)
Cord Blood America (CBAI)
MultiCell Technologies (MCET)
LifeStem International (LSTM)
after almost a decade of limiting taxpayer money for research president Barrack Obama has lifted the restrictions on federal funding of human embryonic stem cell research today.
Back in 2001 George W. Bush restricted funding stem cell research to only a few stem cells that had been created prior to Aug. 9, 2001. This decision was based on politics and religion rather than science. Since then the rest of the world has taken a huge step forward in understanding and bringing commercial products closer to the market than the U.S.
For those unaware embryonic stem cells are pluripotent, meaning they have the ability to form into any cell type that make up the human body. Scientists across the globe (except the U.S.) hope to utilize them to regenerate brain cells lost in Parkinson's, repairing spinal cord injuries as well as treating diabetes, cancer, heart disease, multiple sclerosis and many more defects. Stem cells also help in understanding the human development and growth of diseases. If scientists can map the growth of a disease they will have a greater chance at forming treatments.
Let's think of how many Americans are suffering from the aforementioned ailments and what this research can do for them. I'm sure everyone reading this knows someone important to them that is affected by one of these maladies. Research in the U.S.has not progressed since earlier this decade, cures are a very long time away and lets not even discuss the approval requirement by the FDA. At least this can be seen as a huge step forward to join the rest of the world at bringing about cures that could help millions of people including you and I some day.
|
Comments submitted from other visitors |
|
|
Name : |
??? |
|
Comment: |
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>hi |
More posts, Page # :
1 
Published:Wed, 04 Aug 2010 05:00:00 -0700
BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Food and Drug Administration has designated XOMA 052, ......
Published:Mon, 02 Aug 2010 05:00:00 -0700
BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of antibody therapeutics, announced that the company will host a webcast conference call on Monday, Augus......
Published:Thu, 29 Jul 2010 05:00:00 -0700
BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, announced that the Committee for Orphan Medical Products of the European Medic......
Published:Wed, 04 Aug 2010 07:55:59 -0700
Depomed lead gains among drug stocks a day after it said Pfizer will not file a patent infringement lawsuit to prevent the launch of a painkiller.......
Published:Wed, 04 Aug 2010 08:00:00 -0700
After soaring higher on the FDA approval of its Provenge prostate cancer vaccine in April, volatile Dendreon quickly retreated to well below its pre-approval pricing, but sales fi......
Digg
|
Reddit
|
Mixx
|
del.icio.us
|
Stumble it! |